When: MACD positive cross with histogram turning positive

Then: ANY TWO triggers required for upgrade

When: Fed dovish pivot (FOMC dot-plot shift OR Polymarket hike odds drop <20%)

Then: ANY TWO triggers required for upgrade

When: Two consecutive quarters of operating margin stabilization >12.7%

Then: ANY TWO triggers required for upgrade

When: Confirmed daily close below $327.13 on volume ≥3M shares

Then: Confirms breakdown toward $310 May 2025 structural low

When: Q3 FY26 print reveals core EPS continued to deteriorate ex-tariff with operating margin compressing below 10.0%

Then: Fresh trim execution warranted

When: LOW relative-value gap widens (LOW outperforms HD by >8% over a quarter without sector-wide catalyst)

Then: Signals share-shift narrative has reversed

Existing holders with concentrated exposure should consider trimming into reflexive bounces toward the 50 SMA rather than adding; new capital should wait for disciplined entry with stop 327.13 and base confirmation before deploying at 25 percent starter.

• Synchronized distribution pattern confirmed: death cross in recent months, MACD bearish crossover with histogram expanding to negative 1.28, RSI lower-high divergence, price below all three major moving averages
• Core EPS closer to $4.23 after adjusting reported $4.92 EPS for $0.69 per share tariff benefit versus $4.73 analyst consensus
• Management paused buybacks at current levels, signaling internal concern about valuation or demand fragility
• Forward P/E of 20.88 on a name with negative 4.35 percent year-over-year Q1 FY26 EPS growth represents premium valuation without margin of safety
• 87 percent odds of zero rate cuts in 2026 keep housing turnover frozen at multi-decade lows, threatening big-ticket categories like kitchens, baths, roofing
• Ackman initiated but could already be down 8 to 10 percent; institutional accumulation confirms franchise quality but doesn't signal appropriate entry timing at 334
• Technical entry framework: entry 337.50, stop 327.13, measured move toward 310 to 315 on volume break of 327

→ vs aggressive: Death cross is not 'rearview mirror' when multiple timeframes from short-term momentum to long-term trend show synchronized bearish alignment; empirical data shows buying into confirmed death crosses destroys capital more often than it creates it

→ vs aggressive: Tariff refund of $0.69 per share is one-time accounting benefit, not operational excellence; core EPS of $4.23 versus $4.73 consensus is a meaningful miss on underlying business

→ vs aggressive: Management's choice to use refunds for cost offsetting is a defensive move, not offensive; it signals demand is too fragile to stimulate, not a bullish posture

→ vs aggressive: Institutional accumulation treats Ackman as a buy signal when it should only confirm quality, which is already priced into the HOLD verdict; different uses of the same data

→ vs aggressive: HD has not structurally moved below the macro ceiling; big-ticket categories still depend on housing turnover frozen at multi-decade lows; K-shaped thesis flips from supportive to neutral if higher-income consumer cracks

→ vs aggressive: Premium valuation with forward P/E of 20.88 compresses hard if Q2 FY26 confirms the margin trend instead of reversing it

Maintain core position within portfolio limits; permit only a 25% starter after support reversal; do not buy full position at $337.50; reassess on break below $324.71

• HD is below 10-day EMA, 50-day SMA, and 200-day SMA; MACD below signal line with expanding negative histogram; RSI at 45.49
• Forward earnings multiple of 20.9x on approximately 12% expected earnings growth is reasonable but not a bargain
• SRS distribution business comping above company average may indicate mix shift to professional customers but lacks multi-year confirmation
• $685 million tariff refund is non-recurring; $4.23 EPS figure should not be described as official core EPS without filing verification
• Institutional accumulation confirms quality but not timing; 13F does not reveal cost basis, hedges, or exit discipline
• Q1 showed gross-margin pressure, operating-income decline, and EPS contraction
• Net debt approximately $52 billion; current ratio near 1.08; paused buybacks; 1.2x free-cash-flow dividend coverage is a thin cushion
• Entry at $337.50 offers poor risk/reward: first resistance at $340.60 is only 0.9% above, while stop at $327.13 is 3.1% below; 200-day SMA near $342.41 is only 1.5% above entry
• Starter entry should require HD testing $327.13 to $324.71 area, producing a higher low, close back above $327.13, and improving momentum
• Stronger confirmation would be a close above $340.60 to $342.41 cluster on heavier volume with RSI moving above 50-55 and MACD histogram contracting
• Options strategies (cash-secured put at $327, covered calls) introduce assignment, timing, and opportunity-cost risks rather than free volatility profits
• Base case macro: 87% probability of no rate cuts, 8% recession probability; K-shaped consumer thesis is a cushion not a floor
• Roughly 2.7% dividend yield and approximately $11 billion trailing free cash flow provide support
• Diversification recommended; HD is a quality defensive cyclical, not a true consumer staples substitute

→ vs aggressive: Death cross and technical evidence should not be dismissed; below 10-day EMA, 50-day SMA, 200-day SMA with RSI at 45.49 represents persistent distribution pattern

→ vs aggressive: SRS thesis lacks multi-year record of margin improvement, cash conversion, and competitive gains; one favorable comp does not justify 24-25x multiple

→ vs aggressive: $685M tariff refund is non-recurring; describing $4.23 as official core EPS is premature without filing verification

→ vs aggressive: Institutional accumulation confirms quality not timing; 13F does not reveal cost basis, hedges, liquidity needs, or exit discipline

→ vs aggressive: Roughly 14% YoY and 21% from high does not mean bear case is fully priced; 20.9x forward P/E is reasonable premium not clear bargain

→ vs aggressive: Options strategies are not free volatility profits; cash-secured put obligates purchase if support breaks; covered call caps upside at critical point

→ vs conservative: Death cross is not proof stock must decline; waiting for complete recovery to 200-day SMA can result in paying much higher price if SRS thesis validated early

→ vs conservative: Prediction-market figures (87% no cuts, 8% recession) are probabilities not facts; bearish signals should not override all positive evidence

→ vs conservative: Fundamental data (revenue growth, SRS inflection, dividend yield, free cash flow) supports holding rather than selling outright